UK to resume clinical trial of anti-malaria drug taken by Donald Trump
INSUBCONTINENT EXCLUSIVE:
The trial will see healthcare workers given the anti-malarial drug, and will continue after getting approval to proceed from the UK
Medicines AgencyThis article first appeared/also appeared in Mirror
